Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of apolipoprotein E polymorphisms in levodopa-induced dyskinesia.

Acta neurologica Scandinavica - 1 Feb 2011

Molchadski I, Korczyn A D, Cohen O S, Katzav A, Nitzan Z, Chapman J, Hassin-Baer S

Abstract excerpt

OBJECTIVES: To determine the relationship between apolipoprotein E (APOE) polymorphisms to the time to appearance of levodopa-induced dyskinesia (LID) in patients with Parkinson's disease. METHODS: The APOE genotype of 155 consecutive patients treated with levodopa was determined and its effect on the time of onset of LID was examined using Cox regression model, controlling for gender, age of disease onset, time...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Antiparkinson Agents
Share to Apolipoproteins E

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dyskinesia, Drug-Induced

Share to Gene Frequency

Share to Kaplan-Meier Estimate

Share to Levodopa

Share to Parkinson Disease

Source

Identifiers

PMID: 21108621
DOI: 10.1111/j.1600-0404.2010.01352.x

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of apolipoprotein E polymorphisms in levodopa-induced dyskinesia.PMID 21108621Read ↗

[ApoE polymorphisms and dopaminergic replacement therapy in Parkinson's disease].Semantic proximity Read ↗

Serum Apo Lipoprotein E, Apo Lipoprotein E Gene Polymorphisms, and Parkinson's Disease.Semantic proximity Read ↗

The role of APOE in cognitive trajectories and motor decline in Parkinson's disease.Semantic proximity Read ↗

Dyskinesias in patients with Parkinson's disease: effect of the leucine-rich repeat kinase 2 (LRRK2) G2019S mutation.Semantic proximity Read ↗

The role of APOE alleles in incident Parkinson's disease. The Norwegian ParkWest Study.Semantic proximity Read ↗

Apolipoprotein E genotypes and the risk of Parkinson disease.Semantic proximity Read ↗

Relationship of apolipoprotein E and age at onset to Parkinson disease neuropathology.Semantic proximity Read ↗

APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study.Semantic proximity Read ↗

Sequence variants in SLC6A3, DRD2, and BDNF genes and time to levodopa-induced dyskinesias in Parkinson's disease.Semantic proximity Read ↗

Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease.Semantic proximity Read ↗

Age at onset of Parkinson disease and apolipoprotein E genotypes.Semantic proximity Read ↗

Parkinson's disease and apolipoprotein E: possible association with dementia but not age at onset.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.